Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease
about
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's diseaseAzathioprine or 6-mercaptopurine for induction of remission in Crohn's diseaseOptimization of the treatment with immunosuppressants and biologics in inflammatory bowel diseaseMedical management of Crohn's disease: current therapy and recent advances.A novel immunomodulatory treatment involving mycophenolate mofetil and corticosteroids for pediatric autoimmune cytopenias.Inflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysisManagement of Crohn's disease.Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.Medical management of Crohn's disease.Recent advances in inflammatory bowel disease.Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation.Immunotherapeutic approaches to inflammatory bowel diseases.New developments in the treatment of inflammatory bowel disease.Mycophenolate mofetil for myasthenia gravis: a clear and present controversyUse of mycophenolate mofetil in inflammatory bowel disease.Tacrolimus--finally!Novel biological strategies in inflammatory bowel diseases.Corticosteroid-sparing therapy: practice patterns among uveitis specialistsManagement of ulcerative colitis and Crohn's disease.Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.Management of difficult inflammatory bowel disease: where are we now?Basic immunosuppressive drugs outside solid organ transplantation.Treatment of inflammatory bowel disease: a review of medical therapy.The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel diseaseApplication of prodrugs to inflammatory diseases of the gut.Management of Crohn's disease from efficacy, quality of life and health economic perspectives.Clinical management of inflammatory bowel disease in the organ recipientRisk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease.Drug-induced inflammatory bowel disease and IBD-like conditions.Comparing medical treatments for Crohn's disease.Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review.What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?A Review of Inflammatory Bowel Disease in the Setting of Liver Transplantation.Hematopoietic stem cell transplantation for severe Crohn's disease.A case of new onset Crohn's disease after renal transplantation.Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease.A case of resistant spondyloarthritis (SpA) that responded to tacrolimus and mycophenolate treatment initiated at the time of renal transplantation for unrelated renal failure.
P2860
Q24197676-1919A61B-4065-4B26-B773-F19683D6CE05Q24240676-40789AB0-1EB8-454B-9089-AD00CAA8C43EQ26866940-77A8F24F-D4FC-457F-905C-7C4C972ABB25Q30450875-4224C5B2-4136-404C-9310-1FB134C23B0AQ33435295-4FB2D02D-076A-4CA5-905B-537BD643474DQ33564492-693B22AB-0799-4BAB-BF0B-7F30025B26E4Q33785519-1CB3861D-23BA-4AFA-9F8F-63DDBA469058Q33904308-12A70D14-005F-42B7-9FD0-6F32638CE2E6Q34046139-EBAEEE0E-90B1-480D-8EDC-239817C45BA8Q34188405-E487CB4A-12CB-4C1A-AA3B-7E79AC912ACCQ34267100-8E87EFEB-D86B-4D27-BDBA-8B69CB128F65Q34451989-99C4936F-6570-4570-890B-D4D58D476C69Q34544666-D214F6D9-C43A-48A4-A31F-B00FCA8482EEQ34606062-04D2ACFC-04D9-41E1-B14D-959C5B8F40C0Q34606152-804F88E9-C4A3-43F8-B6D0-0ECA57072FA7Q35768958-91524A11-0174-4114-AFD9-F7D2EDAC022BQ35787653-5499D09F-8789-4D5B-9317-B05F9080E0F5Q35828102-7BCD82FF-4D49-4DC5-82E5-1CED363D82B8Q36004867-C3679AEA-A9D6-4415-9138-AAA3E48F7164Q36175167-69C5D0B1-3721-4DA2-822A-5CEC9E11DF11Q36397453-D0CC5001-FC87-46BD-9980-426A001AABFDQ36407314-3CF236AC-72F2-486A-98C8-9DA312A01C5EQ37058862-CE110E42-C7C9-437D-AEF6-D0706C5E7F10Q37078616-0A57754D-C7B1-4DB0-A4A7-F300C37E0FD1Q37096512-7829B080-B25D-4ED9-BC11-11AB1C7353D3Q37609246-EB74D5C2-3CA0-4C90-8CD9-CCF463661AA7Q37682504-4F5C689F-8594-4973-AA8C-580AB5E0CD6FQ37789693-EF373743-303A-483B-8527-7382B0646593Q38008983-6183749D-5938-4364-8771-A0CE76237EA8Q38162880-AC739117-0F0B-4AFC-9F1B-99EF8C1EA1C2Q38186168-ADCC807D-2842-4F77-A2A1-F003C0352324Q38191583-B9F9C1B4-6246-428A-B79B-E046CE5DD7ECQ38931653-203FD6F2-58EE-45AB-9D91-923612E39C5DQ40551797-930C8CE3-2022-416D-B0E4-F62CD9955AE3Q42141761-13E0D0E2-564F-440A-8919-A27CD0F800B5Q45113442-C22E5168-1E22-437A-AA2F-323A6A1C0673Q45712977-0A634376-D174-4FA5-A574-B70BE694FD09Q52817407-559C3AAE-3E46-4C7C-AA36-8259696E87E1
P2860
Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Randomised trial of mycophenol ...... chronic active Crohn's disease
@ast
Randomised trial of mycophenol ...... chronic active Crohn's disease
@en
type
label
Randomised trial of mycophenol ...... chronic active Crohn's disease
@ast
Randomised trial of mycophenol ...... chronic active Crohn's disease
@en
prefLabel
Randomised trial of mycophenol ...... chronic active Crohn's disease
@ast
Randomised trial of mycophenol ...... chronic active Crohn's disease
@en
P2093
P2860
P356
P1433
P1476
Randomised trial of mycophenol ...... chronic active Crohn's disease
@en
P2093
F Krummenauer
J F Schlaak
K H Meyer zum Büschenfelde
M F Neurath
R Wanitschke
P2860
P304
P356
10.1136/GUT.44.5.625
P407
P577
1999-05-01T00:00:00Z